PRF1 and COVID-19: When we correlated our findings with the outcome of COVID-19, there was a significant decrease in the expression of PRF1 and IFN-γ in CD8+ T cells in patients who developed moderate and severe COVID-19 compared to those who remained in the mild group after the tenth day of illness.